RxSight (RXST) Profit After Tax (2020 - 2026)
RxSight's (RXST) quarterly Profit After Tax came in at -$12.1 million in Q2 2026, down 1.5% on a YoY basis from -$12.3 million in Q2 2025, and up 23.84% quarter-over-quarter from -$15.9 million in Q1 2026.
Analysis
RxSight (RXST) Profit After Tax (2020 - 2026) Analysis & Trends
RxSight (RXST) has reported Profit After Tax for 7 consecutive years, with -$12.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Profit After Tax fell 1.5% year-over-year to -$12.1 million; the trailing twelve-month figure through Jun 2026 stood at -$47.0 million (down 45.0% YoY), and the FY2025 full-year result was -$39.1 million, down 42.26% from the prior year.
- Profit After Tax grew to -$12.1 million in Q2 2026 per RXST's latest filing, from -$15.9 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$5.9 million in Q4 2024 and bottomed at -$17.6 million in Q1 2022.
- Historically, Profit After Tax has averaged -$11.7 million across 5 years, with a median of -$12.0 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Profit After Tax tumbled 158.57% in 2022, then soared 55.96% in 2024.
- Over 5 years, Profit After Tax stood at -$15.6 million in 2022, then jumped by 41.05% to -$9.2 million in 2023, then soared by 35.29% to -$5.9 million in 2024, then sank by 54.26% to -$9.2 million in 2025, then sank by 32.06% to -$12.1 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$12.1 million, -$15.9 million, and -$9.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 241.90 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 201.00 Mn |
| 10 | RxSight | 265.13 Mn | -139.12 Mn | - | -12.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.10 Mn |
| Mar 31, 2026 | -15.88 Mn |
| Dec 31, 2025 | -9.16 Mn |
| Sep 30, 2025 | -9.82 Mn |
| Jun 30, 2025 | -11.92 Mn |
| Mar 31, 2025 | -8.19 Mn |
| Dec 31, 2024 | -5.94 Mn |
| Sep 30, 2024 | -6.34 Mn |
| Jun 30, 2024 | -6.08 Mn |
| Mar 31, 2024 | -9.10 Mn |
| Dec 31, 2023 | -9.18 Mn |
| Sep 30, 2023 | -12.42 Mn |
| Jun 30, 2023 | -13.80 Mn |
| Mar 31, 2023 | -13.21 Mn |
| Dec 31, 2022 | -15.57 Mn |
| Sep 30, 2022 | -16.82 Mn |
| Jun 30, 2022 | -16.73 Mn |
| Mar 31, 2022 | -17.60 Mn |
| Dec 31, 2021 | -15.73 Mn |
| Sep 30, 2021 | -12.68 Mn |